New Clinical Data Point to Use of GlycoMark as Biomarker of SGLT-2 Diabetes Drug Effectiveness and Compliance
RALEIGH, N.C., Oct. 30, 2023 /PRNewswire/ — Precision Diabetes, Inc. announces new studies that show that the GlycoMark blood test,
Read More